From generics dominance to innovation leadership, India’s pharmaceutical sector is scaling rapidly through advanced ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...

Under new pact, India's Zydus Lifesciences plans to initially export medicines to Afghanistan, later begin domestic drug production - Anadolu Ajansı ...

India currently ranks as the world's largest supplier of generic drugs, contributing one in every five generic medicines sold globally. However, it stands 11th in terms of export value. The report, ...

Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export ...

As part of the co-production model, India will set up a pharmaceutical factory in Russia and get access to fertilisers that ...

NEW DELHI, July 25 (Reuters) - India's pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government ...

Jamkas Pharmaceuticals, a Jammu-based Company, has announced the expansion of its third-party pharma manufacturing services ...

The FDA approves two new drugs for gonorrhoea treatment, with Dr. Reddy’s to market one in Thailand and South Africa.

India faces a sharp export decline to the U.S. as steep tariff hikes severely impact major sectors and trade performance.